Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Am J Gastroenterol

Department of Internal Medicine and Section of Psychiatry, Institute of Clinical Neuroscience, Sahlgrenska University Hospital, Göteborg, Sweden.

Published: February 2002

Objectives: Quality of life is reduced in inflammatory bowel disease (IBD). Whether or not this is true in IBD patients in long-standing remission is unclear. Symptoms compatible with irritable bowel syndrome (IBS) are common in IBD patients in remission. The importance of psychological factors in this process is a matter of controversy.

Methods: Forty-three patients with ulcerative colitis (UC) and 40 with Crohn's disease (CD), who had been in remission for at least 1 yr according to laboratory parameters and clinical and endoscopical appearance, were included. These patients completed four different self-administered questionnaires, evaluating GI symptoms, anxiety, depression, and psychological general well-being. The two patient groups were compared with the general population, and within-group comparisons in psychometric scores were made between patients with and without IBS-like symptoms.

Results: The psychological well-being in IBD patients in long-standing remission was similar to that of the general population, despite the presence of more severe GI symptoms. CD patients reported more psychosocial dysfunction, reduced well-being, and GI symptoms than UC patients. Thirty-three percent of UC patients and 57% of CD patients had IBS-like symptoms. The group with IBS-like symptoms (both UC and CD) had higher levels of anxiety and depression and more reduced well-being than those without. Anxiety and reduced vitality were found to be independent predictors for IBS-like symptoms in these patients.

Conclusion: The prevalence of IBS-like symptoms in IBD patients in long-standing remission is two to three times higher than that in the normal population. Psychological factors seem to be of importance in this process. However, as a group IBD patients in remission demonstrate psychological well-being comparable to that of the general population.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2002.05475.xDOI Listing

Publication Analysis

Top Keywords

ibs-like symptoms
20
ibd patients
20
psychological factors
12
patients
12
patients long-standing
12
long-standing remission
12
general population
12
symptoms
9
quality life
8
inflammatory bowel
8

Similar Publications

Background And Purpose: Irritable bowel syndrome (IBS) is a common condition that is challenging to treat, and novel drugs are needed for this condition. Previously, a chronic vicarious social defeat stress (cVSDS) mouse model exhibits IBS-like symptoms. Also agonists of the opioid δ-receptor exert anti-stress effects in rodents with minimal adverse effects.

View Article and Find Full Text PDF

Implication of the enteric glia in the IBS-like colonic inflammation associated with endometriosis.

BMC Womens Health

December 2024

Department of Basic Sciences - Physiology Division, Ponce Health Sciences University, Ponce Research Institute, PO Box 7004, Ponce, 00732-7004, PR, Puerto Rico.

Background: Endometriosis is a complex gynecological disorder characterized by the ectopic growth of endometrial tissue. Symptoms of endometriosis are known to impair the quality of life of patients, and among these are found dysmenorrhea, chronic pelvic pain, and gastrointestinal (GI) issues. GI issues such as painful bowel movements, bloating and constipation or diarrhea, are one of the common reasons for misdiagnosis with irritable bowel syndrome (IBS).

View Article and Find Full Text PDF

Irritable bowel syndrome (IBS) is a functional bowel disorder defined by recurrent abdominal pain, coupled with irregular bowel habits and alterations in the frequency as well as the consistency of stool. At present, IBS is considered as a disease of gut-brain interaction, and an increasing number of studies are focusing on the brain-gut axis. However, the brain regions associated with IBS have not been fully studied yet.

View Article and Find Full Text PDF
Article Synopsis
  • This clinical trial investigated how effective paroxetine and gabapentin are at improving gastrointestinal symptoms, mental health, and overall quality of life in patients with ulcerative colitis during remission.
  • A total of 97 patients were divided into two groups: one received paroxetine (20 mg/day) and the other gabapentin (100 mg increasing to 300 mg over three months), with assessments conducted over three months.
  • Results showed that patients taking paroxetine experienced significantly greater reductions in anxiety and depression, as well as improved quality of life, compared to those taking gabapentin.
View Article and Find Full Text PDF
Article Synopsis
  • * These IBS-like symptoms significantly reduce quality of life and lead to higher healthcare usage, making accurate diagnosis and treatment essential.
  • * A comprehensive approach is recommended for treatment, addressing not only inflammation but also including evidence-based pharmacological options, lifestyle changes, and consideration of psychological factors to improve overall patient care.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!